The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., & Weiner, H. L. (1994) · Science · doi:10.1126/science.7520605 · Cited by 1,973
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,898
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
Lehmann, P. V., Forsthuber, T., Miller, A., & Sercarz, E. E. (1992) · Nature · doi:10.1038/358155a0 · Cited by 1,186
Jenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Partners in transcription: NFAT and AP-1
Macián, F., López-Rodríguez, C., & Rao, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204386 · Cited by 766
Miller, A., Lider, O., Roberts, A. B., Sporn, M. B., & Weiner, H. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.421 · Cited by 732
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694
Self-citationRuddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
The many important facets of T-cell repertoire diversity
Nikolich-Žugich, J., Slifka, M. K., & Messaoudi, I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1292 · Cited by 675
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.
Friedman, A., & Weiner, H. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6688 · Cited by 635
Belghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis
Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M., & Hafler, D. A. (1993) · Science · doi:10.1126/science.7680493 · Cited by 584
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Critchfield, J. M., Racke, M. K., Zúñiga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J., & Lenardo, M. J. (1994) · Science · doi:10.1126/science.7509084 · Cited by 524
McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C., & Miller, S. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.75 · Cited by 518
Self-citationKappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Raz, I., Elias, D., Avron, A., Tamir, M., Metzger, M., & Cohen, I. R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06801-5 · Cited by 508
Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., & Miller, S. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5003 · Cited by 482
Self-citationBailey, S. L., Schreiner, B., McMahon, E. J., & Miller, S. D. (2007) · Nature Immunology · doi:10.1038/ni1430 · Cited by 463
Self-citationOral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy
Whitacre, C. C., Gienapp, I. E., Orosz, C. G., & Bitar, D. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.7.2155 · Cited by 445
An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., & Kuchroo, V. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90169-8 · Cited by 412
Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L., & McDevitt, H. O. (1989) · Cell · doi:10.1016/0092-8674(89)90287-0 · Cited by 389
Lieberman, S. M., Evans, A. M., Han, B., Takaki, T., Vinnitskaya, Y., Caldwell, J. A., Serreze, D. V., Shabanowitz, J., Hunt, D. F., Nathenson, S. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932778100 · Cited by 388
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.013 · Cited by 348
Altered thymic positive selection and intracellular signals in Cbl-deficient mice
Naramura, M., Kole, H. K., Hu, R.-J., & Gu, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15547 · Cited by 336
Vanderlugt, C. J., & Miller, S. D. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80012-4 · Cited by 331
Self-citationInsulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Fife, B. T., Guleria, I., Gubbels Bupp, M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 325
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C., & Bluestone, J. A. (1995) · Immunity · doi:10.1016/1074-7613(95)90063-2 · Cited by 315
Self-citationOral Tolerance: Mechanisms and Therapeutic Applications
Faria, A. M. C., & Weiner, H. L. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60787-7 · Cited by 311
CD3-specific antibody-induced active tolerance: from bench to bedside
Chatenoud, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1000 · Cited by 309
Bitar, D. M., & Whitacre, C. C. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90305-x · Cited by 288
Anandasabapathy (2003) · doi:10.1016/s1074-7613(03)00084-0 · Cited by 285
Metzler, B., & Wraith, D. C. (1993) · International Immunology · doi:10.1093/intimm/5.9.1159 · Cited by 275
Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects
Skyler, J. S., Weinstock, R. S., Raskin, P., Yale, J.-F., Barrett, E., Gerich, J. E., Gerstein, H. C., & the Inhaled Insulin Phase III Type 1 Diabetes Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1630 · Cited by 269
Oral Tolerance: Therapeutic Implications for Autoimmune Diseases
Faria, A. M. C., & Weiner, H. L. (2006) · Journal of Immunology Research · doi:10.1080/17402520600876804 · Cited by 260
Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., & Baecher‐Allan, C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00240.x · Cited by 260
Chaillous, L., Lefèvre, H., Thivolet, C., Boitard, C., Lahlou, N., Atlan-Gepner, C., Bouhanick, B., Mogenet, A., Nicolino, M., Carel, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02579-4 · Cited by 248
Gaur, A., Wiers, B., Liu, A., Rothbard, J., & Fathman, C. G. (1992) · Science · doi:10.1126/science.1279812 · Cited by 247
Bielekova, B., Sung, M.-H., Kadom, N., Simon, R., McFarland, H., & Martin, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3893 · Cited by 241
Martı́n, P., del Hoyo, G. M., Anjuère, F., Arias, C. F., Vargas, H. H., Fernández-L, A., Parrillas, V., & Ardavı́n, C. (2002) · Blood · doi:10.1182/blood.v100.2.383 · Cited by 239
Bilsborough, J., George, T. C., Norment, A., & Viney, J. L. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01606.x · Cited by 225
Barnett, M. L., Kremer, J. M., St. Clair, E. W., Clegg, D. O., Furst, D., Weisman, M., Fletcher, M. J. F., Chasan-Taber, S., Finger, E., Morales, A., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199802)41:2<290::aid-art13>3.0.co;2-r · Cited by 225
Prakken, B. J., Samodal, R., Le, T. D., Giannoni, F., Yung, G. P., Scavulli, J., Amox, D., Roord, S., de Kleer, I., Bonnin, D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400061101 · Cited by 218
Pozzilli, P., Pitocco, D., Visalli, N., Cavallo, M. G., Buzzetti, R., Crinò, A., Spera, S., Suraci, C., Multari, G., Cervoni, M., et al. (2000) · Diabetologia · doi:10.1007/s001250051482 · Cited by 217
Vanderlugt, C. L., Neville, K. L., Nikcevich, K. M., Eagar, T. N., Bluestone, J. A., & Miller, S. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.670 · Cited by 213
Self-citationTherapeutic potential of oral tolerance
Mayer, L., & Shao, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1370 · Cited by 212
Karin, N., Mitchell, D. J., Brocke, S., Ling, N., & Steinman, L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2227 · Cited by 211
Miller, S. D., Wetzig, R. P., & Claman, H. N. (1979) · The Journal of experimental medicine · doi:10.1084/jem.149.3.758 · Cited by 209
Self-citationAharoni, R., Teitelbaum, D., Arnon, R., & Sela, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.634 · Cited by 191
An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide
Pedotti, R., Mitchell, D., Wedemeyer, J., Karpuj, M., Chabas, D., Hattab, E. M., Tsai, M., Galli, S. J., & Steinman, L. (2001) · Nature Immunology · doi:10.1038/85266 · Cited by 185
Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala)
Herold, K. C., Burton, J. B., Francois, F., Poumian-Ruiz, E., Glandt, M., & Bluestone, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16090 · Cited by 177
The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases
Miller, S. D., & Karpus, W. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90173-2 · Cited by 163
Self-citationMiller, S. D., McRae, B. L., Vanderlugt, C. L., Nikcevich, K. M., Pope, J. G., POPE, L., & Karpus, W. J. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00071.x · Cited by 153
Self-citationT-cell signalling and autoimmunity: molecular mechanisms of disease
Ohashi, P. S. (2002) · Nature reviews. Immunology · doi:10.1038/nri822 · Cited by 152
Kohm, A. P., Williams, J. S., Bickford, A. L., McMahon, J. S., Chatenoud, L., Bach, J., Bluestone, J. A., & Miller, S. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4525 · Cited by 145
Self-citationKennedy, M., Tan, L., Canto, M. C. D., Tuohy, V. K., Lu, Z. J., Trotter, J. L., & Miller, S. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.3.909 · Cited by 140
Self-citationOral Tolerance in Experimental Autoimmune Encephalomyelitis
Whitacre, C. C., Gienapp, I. E., Meyer, A. L., COX, K. L., & Javed, N. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb21130.x · Cited by 140
Staeva-Vieira, T., Peakman, M., & von Herrath, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03328.x · Cited by 138
Young, D. A., Lowe, L. D., Booth, S. S., Whitters, M. J., Nicholson, L. B., Kuchroo, V. K., & Collins, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3563 · Cited by 132
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
Utset, T. O., Auger, J., Peace, D., Zivin, R. A., Xu, D., Jolliffe, L. K., Alegre, M., Bluestone, J. A., & Clark, M. R. (2002) · PubMed · Cited by 131
Turley, D. M., & Miller, S. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2212 · Cited by 126
Self-citationDNA immunization to prevent autoimmune diabetes
Coon, B., An, L., Whitton, J. L., & von Herrath, M. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7209 · Cited by 118
Meyer, A. L., Benson, J., Gienapp, I. E., Cox, K. L., & Whitacre, C. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4230 · Cited by 112
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance
Eagar, T. N., Karandikar, N. J., Bluestone, J. A., & Miller, S. D. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<972::aid-immu972>3.0.co;2-m · Cited by 109
Self-citationRaz, I., Avron, A., Tamir, M., Metzger, M., Symer, L., Eldor, R., Cohen, I. R., & Elias, D. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.712 · Cited by 105
Seroogy, C. M., Soares, L. R. B., Ranheim, E. A., Su, L., Holness, C. L. L., Bloom, D. D., & Fathman, C. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.79 · Cited by 96
Smith, C., Eagar, T. N., Strominger, J. L., & Miller, S. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504131102 · Cited by 94
Self-citationOral Tolerance: Overview and Historical Perspectives
Mowat, A. M., Parker, L. A., Beacock‐Sharp, H., Millington, O. R., & Chirdo, F. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1309.001 · Cited by 93
Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes
Slavin, A., Maron, R., & Weiner, H. L. (2001) · International Immunology · doi:10.1093/intimm/13.6.825 · Cited by 92
Smith, C., & Miller, S. D. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.12.002 · Cited by 91
Self-citationKennedy, M., Tan, L., Canto, M. C. D., & Miller, S. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.117 · Cited by 79
Self-citationMukherjee, R., Chaturvedi, P., Qin, H.-Y., & Singh, B. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00114-8 · Cited by 79
Oral Insulin Therapy to Prevent Progression of Immune‐Mediated (Type 1) Diabetes
Ergun-Longmire, B., Marker, J., Zeidler, A., Rapaport, R., Raskin, P., Bode, B. W., Schatz, D., Vargas, A., Rogers, D. G., Schwartz, S. L., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1309.057 · Cited by 70
Alleva, D. G., Maki, R. A., Putnam, A. L., Robinson, J. M., Kipnes, M. S., Dandona, P., Marks, J. B., Simmons, D. L., Greenbaum, C. J., Jimenez, R., et al. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01705.x · Cited by 70
Benson, J., Stuckman, S. S., Cox, K. L., Wardrop, R. M., Gienapp, I. E., Cross, A. H., Trotter, J. L., & Whitacre, C. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6247 · Cited by 70
Samson, M. F., & Smilek, D. E. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2737 · Cited by 69
Warren, K. G., Catz, I., & Wucherpfennig, K. W. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00130-5 · Cited by 67
Tan, L., Kennedy, M., & Miller, S. D. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2748 · Cited by 65
Self-citationE3 Ligases in T Cell Anergy—Turning Immune Responses into Tolerance
Heissmeyer, V., & Rao, A. (2004) · Science s STKE · doi:10.1126/stke.2412004pe29 · Cited by 58
Bai, X., Shi, F., Xiao, B., Li, H., van der Meide, P. H., & Link, H. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00133-1 · Cited by 56
Current Issues in the Treatment of Human Diseases by Mucosal Tolerance
Weiner, H. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1309.053 · Cited by 56
Intravenous antigen adrmnistration as a therapy for autoimmune demyelinating disease
Racke, M. K., Critchfield, J. M., Quigley, L., Cannella, B., Raine, C. S., McFarland, H. F., & Lenardo, M. J. (1996) · Annals of Neurology · doi:10.1002/ana.410390108 · Cited by 51
Braley‐Mullen, H., Tompson, J. G., Sharp, G. C., & Kyriakos, M. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90272-5 · Cited by 51
Kennedy, K. J., Smith, W., Miller, S. D., & Karpus, W. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.1036 · Cited by 50
Self-citationIllés, Z., Stern, J. N. H., Reddy, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403833101 · Cited by 38
A View on Beta Cell Transplantation in Diabetes
PIPELEERS, D. G., Keymeulen, B., Chatenoud, L., Hendrieckx, C., Ling, Z., Mathieu, C., Roep, B. O., & Ysebaert, D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02948.x · Cited by 35
Vandenbark, A. A., Vainiene, M., Ariail, K. S., Miller, S. D., & Offner, H. (1996) · Journal of Neuroscience Research · Cited by 34
Self-citationSriram, S., Schwartz, G. N., & Steinman, L. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90335-0 · Cited by 33
Dua, H. S., Gregerson, D. S., & Donoso, L. A. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90072-w · Cited by 31
Su, X., & Sriram, S. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90128-t · Cited by 29
Vandenbark, A. A., Barnes, D., Finn, T. P., BOURDETTE, D. N., Whitham, R. H., Robey, I., Kaleeba, J. A. R., Bebo, B. F., Miller, S. D., Offner, H., et al. (2000) · International Immunology · doi:10.1093/intimm/12.1.57 · Cited by 27
Self-citationMonetini, L., Cavallo, M. G., Sarugeri, E., Sentinelli, F., Stefanini, L., Bosi, E., Thorpe, R., Pozzilli, P., & the Immunotherapy Diabetes (IMDIAB) group (2004) · Diabetologia · doi:10.1007/s00125-004-1521-5 · Cited by 26
Ruiz, P. J., DeVoss, J., Nguyen, L.-V. T., da Fontoura, P. P., Hirschberg, D. L., Mitchell, D. J., García, K. C., & Steinman, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2688 · Cited by 15
Cited by
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Advances in islet encapsulation technologies
Desai, T., & Shea, L. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.232 · Cited by 427
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 413
Getts, D. R., Martin, A. J., McCarthy, D. P., Terry, R. L., Hunter, Z. N., Yap, W. T., Getts, M. T., Pleiss, M., Luo, X., King, N. J., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2434 · Cited by 392
Self-citationRegulation of Adaptive Immunity; The Role of Interleukin-10
Ng, T. H. S., Britton, G. J., Hill, E. V., Verhagen, J., Burton, B. R., & Wraith, D. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00129 · Cited by 354
Metadata
- Authors
- Miller, S. D., Turley, D. M., & Podojil, J. R.
- Venue
- Nature Reviews Immunology
- Published
- 2007-08-10
- Volume
- 7
- Issue
- 9
- Pages
- 665-677
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2018896468
- Cited by
- 290
- References
- 102
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.